Altasciences Supports Metsera in Obesity Clinical Trials
21 Nov 2024 //
BUSINESSWIRE
Metsera Raises Another $215M for Long-Acting GLP-1
14 Nov 2024 //
BIOSPACE
Metsera Raises $215M for Long-Acting GLP-1 Obesity Treatment
13 Nov 2024 //
BIOSPACE
Amneal And Metsera Partner On Next-Gen Obesity Medicines
01 Oct 2024 //
BUSINESSWIRE
Metsera GLP-1 data slice reveals 7.5% weight loss at 36 days
24 Sep 2024 //
FIERCE BIOTECH